BACKGROUND: Pemphigus is an autoimmune blistering disease. According to a report, in areas of endemic pemphigus foliaceus (EPF) in Peru there are cases of pemphigus vulgaris with epidemiologic, clinical and histopathologic characteristics similar to those of "endemic pemphigus vulgaris" (EPV) in Brazil. OBJECTIVES: To determine the clinical and epidemiologic characteristics of endemic pemphigus and the risk factors of patients for developing complications during treatment. METHODS: A study was carried out from July 2003 to March 2008. The study population was 60 patients with EPF and 7 patients with EPV evaluated in hospitals and clinics in the Peruvian Amazon and Lima. A multivariate analysis was carried out using binary logistic regression. RESULTS: The average age of EPF patients was 31.4 years; 55% were men; 60% presented the generalized clinical variant. Non-compliance with the treatment was seen in 57.1% of the patients. Thirty-five percent presented complications (e.g. pyodermitis and pyelonephritis) during treatment. The risk factors for developing complications during treatment were non-compliance with the treatment and having the generalized clinical form. In the EPV group, the average age was 21.7 years; 71.4% were men. All patients presented with the mucocutaneous clinical variant and the initial presentation consisted of oral mucosa lesions; 71.4% presented complications during treatment, pyodermitis being the most frequent. CONCLUSIONS: Non-compliance with the treatment and the generalized clinical form are risk factors for the development of complications during treatment of patients with EPF. Peru indeed has EPV cases with epidemiologic characteristics similar to EPF. Living in a rural area may represent a risk factor for the development of complications during treatment of patients with EPV.
BACKGROUND: Pemphigus is an autoimmune blistering disease. According to a report, in areas of endemic pemphigus foliaceus (EPF) in Peru there are cases of pemphigus vulgaris with epidemiologic, clinical and histopathologic characteristics similar to those of "endemic pemphigus vulgaris" (EPV) in Brazil. OBJECTIVES: To determine the clinical and epidemiologic characteristics of endemic pemphigus and the risk factors of patients for developing complications during treatment. METHODS: A study was carried out from July 2003 to March 2008. The study population was 60 patients with EPF and 7 patients with EPV evaluated in hospitals and clinics in the Peruvian Amazon and Lima. A multivariate analysis was carried out using binary logistic regression. RESULTS: The average age of EPF patients was 31.4 years; 55% were men; 60% presented the generalized clinical variant. Non-compliance with the treatment was seen in 57.1% of the patients. Thirty-five percent presented complications (e.g. pyodermitis and pyelonephritis) during treatment. The risk factors for developing complications during treatment were non-compliance with the treatment and having the generalized clinical form. In the EPV group, the average age was 21.7 years; 71.4% were men. All patients presented with the mucocutaneous clinical variant and the initial presentation consisted of oral mucosa lesions; 71.4% presented complications during treatment, pyodermitis being the most frequent. CONCLUSIONS: Non-compliance with the treatment and the generalized clinical form are risk factors for the development of complications during treatment of patients with EPF. Peru indeed has EPV cases with epidemiologic characteristics similar to EPF. Living in a rural area may represent a risk factor for the development of complications during treatment of patients with EPV.
Authors: S J Warren; M S Lin; G J Giudice; R G Hoffmann; G Hans-Filho; V Aoki; E A Rivitti; V Santos; L A Diaz Journal: N Engl J Med Date: 2000-07-06 Impact factor: 91.245
Authors: Valeria Aoki; Robert C Millikan; Evandro A Rivitti; Gunter Hans-Filho; Donald P Eaton; Simon J P Warren; Ning Li; Julio Hilario-Vargas; Raymond G Hoffmann; Luis A Diaz Journal: J Investig Dermatol Symp Proc Date: 2004-01
Authors: Luis A Diaz; Luis A Arteaga; Julio Hilario-Vargas; Jesus G Valenzuela; Ning Li; Simon Warren; Valeria Aoki; Gunter Hans-Filho; Donald Eaton; Vandir dos Santos; Thomas B Nutman; Antonio Antunez de Mayolo; Bahjat F Qaqish; Sebastiao A P Sampaio; Evandro A Rivitti Journal: J Invest Dermatol Date: 2004-12 Impact factor: 8.551
Authors: Alex G Ortega Loayza; Willy Ramos; George Elgart; Peter Bouman; Gerardo Jiménez; Jack Avila; Isabel Rojas; María Vilcarromero; Jorge Hurtado; Gisella Lindo; Carlos Galarza Journal: Int J Dermatol Date: 2006-05 Impact factor: 2.736
Authors: Rosicler Rocha-Alvarez; Alex G Ortega-Loayza; Horacio Friedman; Iphis Campbell; Valeria Aoki; Evandro A Rivitti; David Dasher; Ning Li; Luis A Diaz Journal: Arch Dermatol Date: 2007-07
Authors: D P Eaton; L A Diaz; G Hans-Filho; V D Santos; V Aoki; H Friedman; E A Rivitti; S A Sampaio; M S Gottlieb; G J Giudice; A Lopez; E W Cupp Journal: J Med Entomol Date: 1998-03 Impact factor: 2.278
Authors: Francisco González; Ana Maria Sáenz; Antonietta Cirocco; Inés Maria Tacaronte; Javier Enrique Fajardo; Adriana Calebotta Journal: Pediatr Dermatol Date: 2006 Mar-Apr Impact factor: 1.588
Authors: Carla Andréa Avelar Pires; Viviane Brito Viana; Fernando Costa Araújo; Silvia Ferreira Rodrigues Müller; Miguel Saraty de Oliveira; Francisca Regina Oliveira Carneiro Journal: An Bras Dermatol Date: 2014 Jul-Aug Impact factor: 1.896